Therapeutic foods innovator Rritual Superfoods is gaining attention as it helps build the emerging new market for healthful mushroom elixirs as a beneficial superfood.
On the heels of its initial product launch in September and an ECRM Buyer’s Choice Award last month for its attractive marketing and growing market presence (https://ibn.fm/mcl20), Rritual has secured organic certification from the U.S. Department of Agriculture (“USDA”), which provides “trusted, third-party validation of the quality of Rritual’s products” beyond the unregulated claims of many products to feature “all-natural” ingredients, CEO David Kerbel noted (https://ibn.fm/EVcx8).
“We have a premium lineup that features powerful ingredients and with the addition of a Certified Organic seal our consumers can be confident they are making healthy, informed decisions about what they are putting in their body when they purchase Rritual,” Kerbel stated.
Rritual was established earlier this year, amid the outsized health concerns accompanying a worldwide pandemic, with the purpose of helping to relieve stress, heighten cognitive function and boost the immune system through healthful elixirs, shots and mixes.
The company’s initial product line features three select mushroom varieties that enjoy long-standing reputations for their beneficial biological properties. Each mushroom variety is teamed with natural “adaptogens” — herbal substances used to increase the body’s ability to resist biological stress (https://ibn.fm/EKakP).
“The health and wellness benefits of mushrooms and plant-based therapies are backed by decades of scientific research. Rritual’s new line of elixirs embraces that research and provides consumers with an easy way to get a daily dose of the powerful effects,” Rritual President Dr. Mike Hart stated when the product lines were announced (https://ibn.fm/6IutV). The products will be available to consumers throughout North America during the first quarter of the new year, stepping back from the original announcement they’d be available in the fall.
The elixirs and shots will be available in 14-stick packs and in 250-gram tubs, marketed at first through Rritual’s website and the company’s Amazon store before additional retail outlets are joined through the company team’s corporate connections.
The blends include the Chaga mushroom paired with Eleuthero root to boost immunity, Lion’s Mane mushroom paired with Rhodiola root to support cognitive function and brain health, and Reishi mushroom paired with Ashwagandha root to help the body fight anxiety (https://ibn.fm/AEDr1). Each elixir also contains six other functional mushrooms as well as a prebiotic blend featuring inulin and lucuma fruit powder to support immune and digestive health.
Analysts at Research And Markets forecast the overall functional foods industry will attain revenues of $268 billion by 2027 with a growth CAGR of 6.7 percent between 2021 and 2027, demonstrating the public’s interest in consuming highly nutritious foods even when many such products are expensive and may not have rigorous testing to underly their claims (https://ibn.fm/Km4qf). The emergence of the COVID-19 pandemic this year is seen as a significant driver in consumer interest toward functional foods.
For more information, visit the company’s website at https://investors.WeAreRritual.com.
“Mental Fitness is a Daily Ritual”
NOTE TO INVESTORS:The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at http://ibn.fm/Rritual
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
According to a recent study, individuals who have used classic psychedelics like LSD or psilocybin…
There is a growing trend in which parents take tiny doses of psychedelics like LSD…
Walter Reed National Military Medical Center officials confirmed they are awaiting a $4.9m grant to…
A new study has found that while all ethnic and racial groups can benefit from…
A new study that is yet to be peer-reviewed has found that rats given psilocybin…
The American embassy in Peru has warned Americans against taking traditional psychedelics like the ayahuasca…